smarca4-deficient nsclc

Explore academic connections and research related to this keyword

58

Views

1

Total Connections

Search More Keywords

Related Articles & Bibliographies

1

SMARCA4-deficient NSCLC treated with first-line tislelizumab and fruquintinib achieved remarkable tumor regression: case report and literature review.

Dong, Jie; Zhang, Jinli; Pan, Hongming; Wang, Chongwei; Sheng, Jin

2025 Frontiers in immunology DOI: 10.3389/fimmu.2025.1... 91 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

targeted therapy immunotherapy case report precision oncology